AstraZeneca Calms Pricing Jitters, Says US Deal Hit Absorbable

benzinga.com/markets/earnings/25/11/48688666/astrazeneca-calms-pricing-jitters-says-us-deal-hit-absorbable

AstraZeneca Plc (NASDAQ:AZN) on Thursday reported third-quarter 2025 sales of $15.19 billion, up 12% year over year (+10% at constant currency), beating the consensus of $14.80 billion, driven by double-digit growth in oncology, CVRM, and biopharmaceuticals.
The company’s adjusted EPADS…

This story appeared on benzinga.com, 2025-11-06 15:04:09.
The Entire Business World on a Single Page. Free to Use →